New Impact Factor for Translational Gastroenterology and Hepatology: 3.8

Published: 2024-06-21

We are pleased to announce that the Translational Gastroenterology and Hepatology (TGH) has attained its latest impact factor update for the 2023 citation year: 3.8 (Figure 1).

Figure 1. Journal Impact Factor of TGH

Translational Gastroenterology and Hepatology (Transl Gastroenterol Hepatol; TGH; Online ISSN 2415-1289) is an open-access, peer-reviewed online journal that focuses on cutting-edge findings in the field of translational research in gastroenterology and hepatology and provides current and practical information on diagnosis, prevention and clinical investigations of gastrointestinal, pancreas, gallbladder and hepatic diseases. Specific areas of interest include, but not limited to, multimodality therapy, biomarkers, imaging, biology, pathology, and technical advances related to gastrointestinal and hepatic diseases. TGH is indexed by PubMed/PubMed Central, Scopus and Emerging Sources Citation Index (ESCI).

We will strive to follow the best practices in publishing. Our impact factor is an important validation that demonstrates the increased recognition of TGH in the field, and the improved relevance and quality of our articles. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their valuable contributions.

We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in gastroenterology and hepatology to bring more exciting content to readers in the coming future.

Editorial Office
Translational Gastroenterology and Hepatology

June 20, 2024